Eucrates Biomedical Acquisition Corp. (EUCR) is a Blank Checks company listed on NASDAQ. There were no new wire items for EUCR in the last 30 days. The most recent was published May 8, 2023.
Latest news
25 items- SECSEC Form 15-12G filed by Eucrates Biomedical Acquisition Corp.15-12G - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
- SECSEC Form 25-NSE filed by Eucrates Biomedical Acquisition Corp.25-NSE - Eucrates Biomedical Acquisition Corp. (0001822929) (Subject)
- SECSEC Form 10-K filed by Eucrates Biomedical Acquisition Corp.10-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
- NEWSReported Late Tuesday April 11, Eucrates Biomedical Acquisition Corp. Announces Liquidation; Co To Redeem All Outstanding Shares At A Per-Share Redemption Price Of ~$10Eucrates Biomedical Acquisition Corp. (NASDAQ:EUCR) (the "Company") announced the following today: The Company anticipates that it will not be able to consummate an initial business combination within the time period required by its Amended and Restated Memorandum and Articles of Association. Accordingly, the Company intends to dissolve and liquidate in accordance with the provisions of its Amended and Restated Memorandum and Articles of Association. As part of that dissolution and liquidation, the Company will redeem all of the outstanding ordinary shares that were included in its initial public offering (the "Public Shares") at a per-share redemption price of approximately $10.00. A
- SECEucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
- PREucrates Biomedical Acquisition Corp. Announces LiquidationNEW YORK, April 11, 2023 /PRNewswire/ -- Eucrates Biomedical Acquisition Corp. (NASDAQ:EUCR) (the "Company") announced the following today: The Company anticipates that it will not be able to consummate an initial business combination within the time period required by its Amended and Restated Memorandum and Articles of Association.Accordingly, the Company intends to dissolve and liquidate in accordance with the provisions of its Amended and Restated Memorandum and Articles of Association.As part of that dissolution and liquidation, the Company will redeem all of the outstandi
- SECEucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation8-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
- SECSEC Form NT 10-K filed by Eucrates Biomedical Acquisition Corp.NT 10-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
- SECEucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
- 13D/GSEC Form SC 13G/A filed by Eucrates Biomedical Acquisition Corp. (Amendment)SC 13G/A - Eucrates Biomedical Acquisition Corp. (0001822929) (Subject)
- SECSEC Form 10-Q filed by Eucrates Biomedical Acquisition Corp.10-Q - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
- 13D/GSEC Form SC 13G filed by Eucrates Biomedical Acquisition Corp.SC 13G - Eucrates Biomedical Acquisition Corp. (0001822929) (Subject)
- SECEucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation8-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
- SECEucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
- SECEucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure8-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
- SECSEC Form DEF 14A filed by Eucrates Biomedical Acquisition Corp.DEF 14A - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
- SECSEC Form PRER14A filed by Eucrates Biomedical Acquisition Corp.PRER14A - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
- SECSEC Form PRE 14A filed by Eucrates Biomedical Acquisition Corp.PRE 14A - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
- SECSEC Form 10-Q filed by Eucrates Biomedical Acquisition Corp.10-Q - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
- SECSEC Form 10-Q filed by Eucrates Biomedical Acquisition Corp.10-Q - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
- SECSEC Form NT 10-Q filed by Eucrates Biomedical Acquisition Corp.NT 10-Q - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
- SECSEC Form 10-K filed by Eucrates Biomedical Acquisition Corp.10-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
- SECSEC Form NT 10-K filed by Eucrates Biomedical Acquisition Corp.NT 10-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
- 13D/GSEC Form SC 13G filed by Eucrates Biomedical Acquisition Corp.SC 13G - Eucrates Biomedical Acquisition Corp. (0001822929) (Subject)
- 13D/GSEC Form SC 13G/A filed by Eucrates Biomedical Acquisition Corp. (Amendment)SC 13G/A - Eucrates Biomedical Acquisition Corp. (0001822929) (Subject)
EUCR FAQ
7 questionsWhat does Eucrates Biomedical Acquisition Corp. do?
Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.What is the latest news on EUCR?
Quantisnow has not tracked any new filings, ratings or press releases for EUCR in the last 30 days. The most recent wire item was published on May 8, 2023.Where does EUCR stock trade?
Eucrates Biomedical Acquisition Corp. (EUCR) is listed on NASDAQ.What sector and industry is EUCR in?
Eucrates Biomedical Acquisition Corp. operates in the Finance sector, Blank Checks industry.When did Eucrates Biomedical Acquisition Corp. go public?
Eucrates Biomedical Acquisition Corp. (EUCR) completed its IPO in 2020.What companies are similar to EUCR?
Notable peers in the same industry include TACO (Berto Acquisition Corp.), INV (Innventure Inc.), PRE (Prenetics Global Limited), OXSQ (Oxford Square Capital Corp.), ILLU (Illumination Acquisition Corp I). Compare EUCR side-by-side with any of them on Quantisnow.How can I track EUCR on Quantisnow?
Quantisnow aggregates Eucrates Biomedical Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EUCR to receive live email and push alerts on every new disclosure.